Overview
Adverse reactions are harmful or unintended responses to medical interventions, encompassing adverse drug reactions to medicines, reactions to vaccines, and hypersensitivity to therapeutic agents. Adverse drug reactions are conventionally distinguished into type A, dose-dependent and predictable extensions of a drug's pharmacology, and type B, idiosyncratic and immune-mediated, with severity ranging from mild and self-limiting to serious and life-threatening. They arise through pharmacological, toxic, allergic, and idiosyncratic mechanisms, are influenced by dose, drug interactions, and patient factors, and impose clinical and economic burdens that make pharmacovigilance and causality assessment essential. Vaccine reactions, though generally mild and local, are similarly monitored for rare serious events. The peer-reviewed work assembled here engages these themes: adverse-drug-reaction patterns and their direct costs in patients on antiretroviral therapy, toxicity of iodinated radiographic contrast agents, characterization of a vaccine and broader vaccine-hesitancy considerations, cross-reactivity between cyclo-oxygenase inhibitors in patients hypersensitive to NSAIDs, drug-induced fever and pulmonary embolism as adverse events, and reviews of toxicology and drug-safety issues. Across these studies adverse reactions appear through drug- and contrast-induced toxicity, immunological cross-reactivity, vaccine safety, and the costs and management of adverse events. The collection situates adverse reactions as a central concern of clinical pharmacology and patient safety, spanning their mechanisms, risk factors, detection, and prevention across drug and vaccine exposures.
Research published in this journal
12 peer-reviewed articles, ranked by relevance. Each links to its DOI.
The Toxicity of Iodinated Radiographic Contrast Agents in the Clinical Practice
Characterization of the Vaccine Abdala
The Combination of Fractionated Erbium:YAG Laser Skin Microporation and Topical Imiquimod Is A New, Safe And Efficient Strategy for the Treatment of Actinic Keratosis and Basal Cell Carcinoma: Report of Two Pilot Studies
Efficacy of The Immunotargeting Therapeutic Antibody Trastuzumab in HER2-Positive Advanced Gastric Cancer: A Meta-Analysis
Evaluation of Direct Cost of Adverse Drug Reactions to Highly Active Antiretroviral Therapy in Indian Human Immunodeficiency Virus Positive Patients
Cross-Reactivity between COX-2 Inhibitors in Patients with Cross-Reactive Hypersensitivity to NSAIDs
Osteoarthritis Depression Impacts and Possible Solutions Among Older Adults: Year 2021-2022 in Review
Vaccine Hesitancy: A significant Challange
Lenalidomide-Induced High Grade Fever in a Patient with Multiple Myeloma: A Case Report
Toxicology and Drug Safety Issues: A Review Article
Yasmin Induced Pulmonary Embolism: a Case Report
How this research is being cited
The 12 articles above have been cited 35 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.
-
Rupam Saha et al. · 2025 · Medicine in Novel Technology and Devices
-
Ibrahim Halil Kenger et al. · 2025 · Journal of Applied Toxicology
-
Yuping Zhang et al. · 2025 · Biomaterials
-
2025 · Journal of Applied Toxicology
-
2025 · Biomaterials
-
2025 · Medicine in Novel Technology and Devices
-
Hajin Kim et al. · 2024 · Electronics
-
2024 · Electronics
A sample of recent works citing this journal's research on Adverse Reactions, linking to each citing work.